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Sepsis, as defined by the Surviving Sepsis Campaign (SSC) in 2012,[1] 
is the presence of a probable or documented infection together with 
systemic manifestations of an infection.
In 2004, the World Health Organization[2] listed three infective 
causes, namely lower respiratory tract infection, diarrhoeal disease 
and tuberculosis, on their top ten list of causes of death, which 
is similar to mortality reports documented in the 2013 Western 
Cape Mortality Profile.[3] This highlights the fact that sepsis and its 
sequelae – which were originally caused by an infection – are major 
contributors to the local and global burden of disease.
To date there are virtually no accurate data on the incidence and 
prevalence of or mortality rates for sepsis, severe sepsis and septic 
shock in developing countries. Mortality rates have been reported to 
be as high as 30% for sepsis, 40% for severe sepsis and 80% for septic 
shock[4-6] in developed countries. Septic shock is still the leading cause 
of death in intensive care units worldwide. [5] Data from developed 
countries show a continuous increase in the incidence of sepsis, 
further emphasising the need to review management protocols in 
order to reduce morbidity and mortality.
In developed countries, the implementation of protocols for the 
identification of sepsis and for its management have contributed 
to a decline in mortality rates.[7] In low-income countries, prob-
lems such as access to healthcare, cost constraints, lack of 
resources and delayed presentation of patients with sepsis make 
it difficult to implement protocols based on the patient profile of 
developed countries. In sub-Saharan Africa there has therefore 
been a widespread shift towards the development of cost-effective 
protocols specifically suited to the local epidemiological and 
ecological characteristics. [8,9] In 2006, a Ugandan-based prospective 
study assessed the management and outcomes of hospitalised 
patients with severe sepsis syndromes. Approximately 85% of 
their sample were HIV-positive. Factors contributing to mortality 
included inadequate fluid administration, lack of uniformity in 
administration of antibiotics appropriate to the source of sepsis, and 
delay in antibiotic administration.[8] A follow-up prospective study 
was done in 2008 using the previous study as the observation cohort. 
Interventions included early appropriate antibiotic and intravenous 
fluid administration. Mortality at 30 days was significantly lower 
in the intervention cohort compared with the observation cohort, 
leading to the conclusion that simple and inexpensive management 
can improve outcome.[8,9]
Currently no data are available regarding sepsis management in 
our unique setting in South Africa (SA). We hope to pilot the way 
for further research in this field.
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Background. Currently there is little information on the identification, management and outcomes of patients with sepsis in developing 
countries. Simple cost-effective measures such as accurate identification of patients with sepsis and early antibiotic administration are 
achievable targets, within reach without having to make use of unsustainable protocols constructed in developed countries.
Objectives. To assess the ability of clinicians at a district-level hospital to identify and manage sepsis, and to assess patient outcome in terms 
of in-hospital mortality and length of hospital stay given the above management.
Methods. A retrospective descriptive study design was used, analysing data from the routine burden of disease audit done on a 3-monthly 
basis at Karl Bremer Hospital (KBH) in the Western Cape Province, South Africa.
Results. The total sample size obtained was 70 patients, of whom 18 (25.7%) had an initial triage blood pressure indicative of sepsis-induced 
hypotension. However, only 1 (5.5%) of these 18 patients received an initial crystalloid fluid bolus of at least 30 mL/kg. The median time 
that elapsed before administration of antibiotics in septic shock was 4.25 hours. Furthermore, a positive delay in antibiotic administration 
(p=0.0039) was demonstrated. The data also showed that 8/12 patients (66.7%) with septic shock received inappropriate amounts of fluids. 
The in-hospital mortality rate for sepsis was 4/24 (16.7%), for severe sepsis 11/34 (32.3%) and for septic shock a staggering 9/12 (75.0%).
Conclusions. The initial classification process and management of sepsis by clinicians at KBH is flawed. This inevitably leads to an increase 
in in-hospital mortality.
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Objective
The primary objective was to determine the efficacy of sepsis 
identification and management by clinicians at Karl Bremer Hospital 
(KBH), a large district-level hospital in Cape Town, SA. Furthermore, 
we aimed to determine the demographics of patients presenting with 
sepsis, the burden of sepsis and its management, and mortality rates 
and length of hospital stay among patients admitted. Key determinants 
of efficacy were assessed using guidelines outlined in the SSC[1] as a 
means of comparison. The SSC, initially published in 2004, reviewed 
data on the management of severe sepsis and septic shock. The 
recommendations are intended to be best practice and not standard 
of care.
Methods
Setting
KBH is a large district-level hospital with a total of 310 beds, servicing 
an average of 11 000 patients per month. The estimated total cost per 
patient per day is ZAR2 105.90 for a ward admission. However, ~72% 
of the patients are classified as earning either no income or <ZAR3 000 
per month, and are therefore not obliged to pay the full fee. A four-
bed high-care unit shared by all the departments is able to manage 
ventilated patients. However, if a prolonged high-care admission is 
anticipated, the patient will need to be transferred to a fully equipped 
intensive care unit managed by a dedicated team at a tertiary facility 
such as the nearby Tygerberg Hospital. Additionally, the emergency 
department (ED) at KBH has three resuscitation beds.
Study design
A retrospective descriptive study design was used. The internal 
medicine department at KBH performs a routine burden of disease 
audit on a 3-monthly basis. Data for the audit are obtained from 
triplicate discharge letters, hospital transfer notes and death certification 
summaries containing all relevant information on the patient’s hospital 
stay, from admission to discharge or death. Data from the burden of 
disease audit for November 2015 - January 2016 were reviewed. For a 
patient to be selected for the study, the data from the audit sheet had 
to state any one of the key words ‘sepsis’, ‘severe sepsis’ or ‘septic shock’ 
as the diagnosis at discharge or death. The suspected or confirmed 
infection had to have been present at ED presentation for the patient 
to qualify for the study. Data were assessed using a data collection sheet 
compiled by the authors that focused specifically on clinical and blood 
gas measurements that could be used in the ED to classify patients 
as having sepsis, severe sepsis or septic shock. Time to first-dose 
antibiotics (grade 1B evidence based on the SSC[1]), source-appropriate 
antibiotics (grade 1B), amount of intravenous fluids (grade 1C) and 
arterial blood gas/lactate measurement were also assessed.
Once the data were obtained, we retrospectively classified patients 
into the sepsis, severe sepsis or septic shock groups based on the 
I. Sepsis
Widespread systemic manifestations due to the existence 
of an infection. The systemic manifestations could be any 
of the following (adapted from SSC[1]):
General variables:
• Fever (>38.3°C)
• Hypothermia (core temperature <36°C)
• Heart rate >90 bpm
• Tachypnoea, respiratory rate >25/min
• Altered mental status
• Significant oedema or positive fluid balance (>20 mL/kg 
over 24 h)
• Hyperglycaemia (plasma glucose >140 mg/dL or  
7.7 mmol/L) in the absence of diabetes
Inflammatory variables:
• Leukocytosis (white cell count >10 × 109/L) or leukopenia 
(white cell count <4 × 109/L)
• Plasma C-reactive protein >4 mg/L
Haemodynamic variables:
• Arterial hypotension (systolic blood pressure <90 mmHg, 
mean arterial pressure <70 mmHg)
Organ dysfunction variables:
• Arterial hypoxaemia (PaO2/FiO2 ratio <300)
• Acute oliguria (urine output <0.5 mL/kg/h for at least 2 h 
despite adequate fluid resuscitation)
• Raised creatinine (>44.2 µmol/L)
• Coagulation abnormalities (INR >1.5 or aPTT >60 s)
• Ileus (absent bowel sounds)
• Thrombocytopenia (platelet count <100 × 109/L)
• Hyperbilirubinaemia (plasma total bilirubin >22 µmol/L)
Tissue perfusion variables:
• Hyperlactataemia (>1 mmol/L)
• Decreased capillary refill or mottling
II. Severe sepsis 
Sepsis PLUS acute organ dysfunction or tissue 
hypoperfusion.
Sepsis-induced hypotension:
• Systolic blood pressure <90 mmHg, or
• Mean arterial pressure <70 mmHg, or
• Systolic blood pressure decrease >40 mmHg
Organ dysfunction variables:
• Arterial hypoxaemia (PaO2/FiO2 ratio <300)
• Acute oliguria (urine output <0.5 mL/kg/h for at least 2 h 
despite adequate fluid resuscitation)
• Raised creatinine (>45 µmol/L)
• Coagulation abnormalities (INR >1.5 or aPTT >60 s)
• Ileus (absent bowel sounds)
• Thrombocytopenia (platelet count <100 × 109/L)
• Hyperbilirubinaemia (plasma total bilirubin >22 µmol/L) 
Tissue perfusion variables:
• Hyperlactataemia (>1 mmol/L)
• Decreased capillary refill or mottling
III. Septic shock
Severe sepsis PLUS evidence of tissue hypoperfusion not 
reversed with effective fluid resuscitation.
Sepsis-induced tissue hypoperfusion:
 Blood lactate concentration >4 mmol/L
OR
Sepsis-induced hypotension (as above)
Fig. 1. Definitions used for the classification of sepsis. (SSC = Surviving Sepsis Campaign; PaO2 = partial pressure of arterial oxygen; FiO2 = fractional inspired 
oxygen; INR = international normalised ratio; aPTT = activated partial thromboplastin time.)
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information that had been available to the casualty doctor at the time 
of presentation. Definitions used for the classification of sepsis are 
set out in Fig. 1.
Statistical analysis
All data collected were captured onto a Microsoft Excel database, 
version 2013 (Microsoft, USA). Data analysis was done in Microsoft 
Excel, version 2013, and statistical analysis in Statistica, version 12 
(StatSoft, USA). The level of statistical significance was set at p<0.05. 
The sign test was used to compare descriptive variables. To assess for 
data association, logistical regression testing and negative binomial 
regression testing were performed, with the data then being presented 
as odds ratios (ORs) with 95% confidence intervals (CIs).
Ethics approval
Ethics approval was obtained from the Health Research Ethics 
Committee at the Stellenbosch University (ref. no. N15/10/103).
Results
Of the 1 000 patients reviewed in the burden of disease audit, 70 
(7.0%) were included in the study. Of the 70 patients, 34 (48.5%) 
were male and 36 (51.4%) were female. The overall mean (standard 
deviation (SD)) age of patients presenting with a sepsis syndrome was 
48 (9.5) years (minimum 17, maximum 85). A total of 25 patients 
(35.7%) were HIV-positive. The most common infective cause for 
sepsis identified by emergency personnel, across all the grades, was a 
lower respiratory tract infection. Not surprisingly, diarrhoeal disease/
acute gastroenteritis was the second most common diagnosis made 
(Figs 2 - 4).
Based on the data collection and subsequent sepsis subgrouping, 
evaluated using the initial information available to the casualty doctor, 
24/70 patients (34.2%) were classified as having sepsis, 34/70 (48.6%) 
as having severe sepsis and 12/70 (17.1%) as having septic shock. 
However, 18/24 (75.0%) of patients with sepsis, 8/34 (23.6%) with 
severe sepsis and 3/12 (25.0%) with septic shock did not have their 
arterial blood gas or lactate level measured at initial presentation. 
Furthermore, no patient who had an initial lactate level measured had a 
repeat level measured to assess lactate clearance or fluid responsiveness. 
As a result, many patients who should probably have been classified as 
having septic shock were classified as having severe sepsis based on 
adherence to definitions. A total of 18/70 patients (25.7%) had an initial 
triage blood pressure indicative of sepsis-induced hypotension, but 
only 1/18 (5.6%) of these received an initial crystalloid fluid bolus of at 
least 30 mL/kg and subsequent immediate blood pressure recheck for 
fluid responsiveness. Furthermore, 6/18 patients (33.3%) had no initial 
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Fig. 4. Suspected sources of septic shock.
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arterial blood gas or lactate level measured, so 
we had no way of knowing whether the patient 
was initially classified as having severe sepsis or 
septic shock, forcing us to assign patients to the 
severe sepsis group.
The antibiotic most frequently prescribed 
for sepsis, across all the grades, was ceftriaxone 
(Fig. 5). Bearing in mind the literature review[1] 
mentioned above regarding source-appropriate 
antibiotics, 55/70 patients (78.5%) were con-
sidered to have received the correct antibiotics 
for the respective source. However, no HIV-
positive patient in the study received cover for 
Mycobacterium tuberculosis or Pneumo cystis 
jiroveci pneumonia during the first 24 hours 
after presentation to hospital, despite the clini-
cian having a documented suspicion thereof.
Interestingly, it is also important to note 
that 7/70 (10.0%) of the patients received 
no antibiotics during the first 24 hours after 
presentation, despite being identified by the 
casualty doctor as having a possible infective 
cause for their clinical symptoms. In these 
cases, the probable cause of sepsis was equally 
distributed between acute gastro enteritis and 
an unknown source. Of these patients, 3/7 
(42.9%) could be classified as having septic 
shock based on the initial lactate level.
The median time that elapsed before 
admini stration of antibiotics during the 
first 24 hours after presentation, across all 
grades of sepsis, was 3.63 hours for sepsis 
(range 1.67 - 10.30), 1.58 hours for severe 
sepsis (range 1.00 - 2.83) and 4.25 hours 
for septic shock (range 1.00 - 23.98). Here 
it is important to note that the above are 
times from consultation with the attending 
doctor to antibiotic administration, which 
depending on how long patients had to 
wait to see a doctor, may differ considerably 
from the times from initial presentation at 
the emergency department to receiving an 
antibiotic. Unfortunately the latter could not 
be assessed because initial presenting times 
were not documented. To assess whether 
antibiotics were given within the 3-hour 
time frame for sepsis and severe sepsis, 
the sign test was used to extrapolate the 
data. The results showed that there was 
no delay in antibiotic administration for 
sepsis or severe sepsis (p=0.2706 for sepsis 
and p=0.9997 for severe sepsis), bearing in 
mind that the 3-hour mark was used as the 
cut-off for optimal time to initial antibiotic 
administration. For septic shock, however, a 
cut-off of 1 hour was used for optimal time 
to antibiotic administration, and here the 
sign test showed a positive delay in antibiotic 
administration (p=0.0039).
With regard to the early appropriate 
intravenous fluid administration discussed 
above, the data showed that 5/24 (20.8%) of 
patients with sepsis, 8/34 (23.6%) with severe 
sepsis and 8/12 (66.7%) with septic shock 
received inappropriate amounts of fluids. As 
mentioned above, only one patient received 
an initial fluid bolus of at least 30 mL/kg for 
sepsis-induced hypo tension. Pearson’s χ2 test 
showed a positive association between septic 
shock and inappropriate intravenous fluid 
admini stration (p=0.009). Furthermore, the 
pro portion of patients with septic shock who 
received appropriate intravenous fluids was 
less than half the proportions in the sepsis 
and severe sepsis groups. As mentioned 
above, no patient in our study had repeat 
arterial blood gas measurements to assess 
lactate clearance, a marker of response to 
therapy. Also, no invasive measures such 
as central venous pressures or arterial line 
blood pressure readings were used to assess 
fluid responsiveness optimally during the 
first 24 hours of management.
Overall, the outcome of patients in the 
study was determined by discharge or in-hos-
pital mortality, the in-hospital mortality rate 
for sepsis being 4/24 (16.7%), that for severe 
sepsis 11/34 (32.3%) and that for septic shock 
a staggering 9/12 (75.0%) (Fig. 6). The mean 
(SD) age of the patients who died, across 
all sepsis syndromes, was 53 (9.5) years. The 
mean length of stay for all sepsis syndromes 
was 6.3 (2.3) days.
Logistic regression testing to investigate 
for possible associations between in-hospital 
mortality rates and various sepsis manage-
ment principles revealed a positive associa-
tion between in-hospital mortality and the 
following:
• Time to first dose of antibiotic (OR 1.07, 
95% CI 1.01 - 1.14; p=0.027). For every 
1 hour’s delay in antibiotic administration, 
the chance of death increased by 7%.
• Source-appropriate antibiotics (OR 0.17, 
95% CI 0.05 - 0.59; p=0.005). The chance 
of death for patients who received source-
appropriate antibiotics was 83% less than 
for those who did not.
• Early appropriate ad mini stration of intra-
venous fluid (OR 0.33, 95% CI 0.11 - 0.95; 
p=0.040). Appropriate intravenous fluids 
were asso ciated with a 67% reduction in 
in-hospital mortality.
Discussion
The findings reported above reflect clear 
faults in the identification of sepsis at KBH 
and its resultant suboptimal management.
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Evidence to support poor recognition of sepsis syndromes includes 
lack of adequate fluid boluses for patients who met the definition 
for hypotension at admission, indicating that clinicians did not 
recognise the importance of hypotension as a clinical indicator of 
organ dysfunction in sepsis. Clinicians at KBH do not have access 
to laboratory results for a minimum of 12 hours after a consultation 
and are therefore forced to use their clinical judgement regarding the 
severity of disease, aided by blood pressure monitoring, urine output 
and blood gas measurement for lactate, and partial pressure of arterial 
oxygen/fractional inspired oxygen ratios to assess fluid responsiveness 
and organ dysfunction. Further evidence of inadequate identification of 
sepsis are the 3/7 patients who could be classified as having septic shock 
on the basis of the initial blood gas lactate measurement but did not 
receive antibiotics for the first 24 hours after presentation. This indicates 
a poor understanding of the effect of delayed antibiotic administration 
on mortality rates related to sepsis. The overall median time to initial 
antibiotic administration was 4.25 hours for septic shock v. 1.58 hours 
for severe sepsis. Because these three patients were included in the 
count for patients with septic shock, the median time to initial antibiotic 
administration in this subgroup increased significantly.
Kumar et al.[6] showed a 7.6% decrease in survival for every 1 hour’s 
delay in antibiotic therapy over the ensuing 6 hours. Similarly, we 
found a 7% increase in mortality for every hour’s delay in antibiotic 
administration. As mentioned above, the median time to the first 
dose of antibiotic was measured as the time from consultation with 
a doctor to initial antibiotic administration. The minimum waiting 
time in the ED from arrival at the hospital to doctor consultation is 
45 - 60 minutes. None of the patients managed, regardless the grade 
of sepsis, are therefore achieving the targets of the 3-hour bundle and 
1-hour administration time frames. This can be attributed to both 
poor identification, as discussed above, and resource limitations. 
The nursing staff in the ED who are responsible for drug and fluid 
administration often oversee the management of 10 - 20 patients at 
a time, which makes it difficult for them to perform important tasks 
timeously. Bed constraints and lack of resuscitation room availability 
mean that severely ill patients often lie in the general ED area where 
there is no appropriate monitoring.
In our study, not receiving source-appropriate antibiotics had a 
positive association with mortality. Leibovici et al.[10] showed that 
survival improved when empirical antibiotic treatment matched the in 
vitro susceptibility of the likely pathogen. The concern in this regard is 
that we have limited evidence regarding source-appropriate antibiotics 
in an environment with a high prevalence of HIV infection. Infective 
aetiologies in sub-Saharan Africa differ from those reported in the SSC 
guidelines,[1] and in fact certain studies reviewed by the SSC committee 
excluded HIV-positive patients, giving rise to the questions which are 
the early source-appropriate antibiotics that should be administered 
given the unique sub-Saharan African environment, and what the 
effect on outcome is in HIV-positive patients.
Appropriate intravenous fluid administration is a further area 
for debate in the HIV-prevalent SA setting. The studies in Uganda 
and Zambia[8,9,11] reported concerns that in such a setting, large fluid 
boluses could worsen respiratory failure. However, we found a 67% 
reduction in in-hospital mortality with appropriate intravenous fluid 
administration. Again, lack of appropriate monitoring in the ED makes 
appropriate fluid administration difficult, as patients receiving large 
fluid boluses run the risk of becoming fluid overloaded unless they are 
adequately monitored.
Recommendations
It is evident that education for all healthcare providers involved in the 
identification and management of sepsis is necessary. Formulation of 
a suggested process, perhaps in the form of a sepsis check sheet, could 
lead to improved management. Re-evaluation of outcomes in the form 
of length of hospital stay and in-hospital mortality will be necessary 
in order to evaluate the impact of such a process. Further areas that 
need attention are earlier availability of laboratory results, which aids 
decision-making, and more doctors in the ED to decrease waiting time.
Conclusions
The main aim of our study was to evaluate identification and 
management of the sepsis syndromes at a district-level hospital in the 
Western Cape. We concluded that the initial classification of sepsis, 
severe sepsis and septic shock by our clinicians is flawed. This is 
largely due to lack of understanding on the part of medical personnel 
of the clinical evidence needed to support the classification process. 
This clinical evidence does not depend on delayed laboratory results, 
but on basic examinations and investigations available in the ED. 
Priorities in the management of the sepsis syndromes include early 
source-appropriate antibiotics and early appropriate intravenous fluid 
administration. These should be the cornerstones of management, 
and can be instituted regardless of resource availability. Finally, it 
is evident that additional research is needed in the field of sepsis 
identification and management in a resource-limited setting. However, 
basic management principles can nevertheless be implemented, with 
the potential for an enormous impact on patient survival.
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